Table 1.

Demographic information and treatment regimens

Total number of patients	6
Male (%)	4 (67)
Female	2 (33)
Median age (Range)	56.5 (10 mo–72 yrs)
HIV status
Positive (%)	2 (33)
Negative	4 (67)
Therapy for CMV retinitis patients*
Intravitreal foscarnet** (%)	6 (100)
Oral valganciclovir	5 (83)
IV foscarnet or ganciclovir	2 (33)
Ganciclovir implant	1 (16)

^*This includes all medications administered after ocular fluid was obtained for PCR testing, including the initial foscarnet injection in all cases.

^**Foscarnet administered in a dose of 2.4 mg/0.1 ml

Abbreviations HIV Human immunodeficiency virus PCR Polymerase chain reaction CMV Cytomegalovirus VZV Varicella zoster virus IV Intravenous